Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Calumet, Inc. (CLMT) Financial Statements

Calumet, Inc. (CLMT) reported trailing twelve-month revenue of $4.6B (up 12.8% year on year) and net income of -$136.8M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $73.5M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

CLMTCalumet, Inc.Follow CLMT — free
Specialty Chemicals · Basic Materials
—
Price chart with a free account
Market cap
4.3B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
6 Nov, in 13 days

Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.

LineFY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Revenue4.184.194.144.59
Gross profit0.450.230.250.30
Operating income0.270.010.110.05
Pre-tax income0.05-0.22-0.13-0.27
Income tax0.000.00-0.09-0.14
Net income0.05-0.22-0.03-0.14
Diluted EPS ($)—-2.67-0.39-1.55
Diluted shares (bn)0.0800.0830.087—

USD billions · SEC XBRL

Calumet, Inc. — questions

What is Calumet, Inc.'s revenue?
$4.6B over the twelve months to 2026-06-30, up 12.8% year on year, from its 10-Q and 10-K filings.
What is Calumet, Inc.'s net income?
-$136.8M over the twelve months to 2026-06-30.
What is Calumet, Inc.'s free cash flow?
$73.5M over the twelve months to 2026-06-30.
What are Calumet, Inc.'s diluted earnings per share?
$-1.55 over the twelve months to 2026-06-30.

Every figure on this page comes from Calumet, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.